| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.03 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.04 |